Genomic Health Director Buys 79.9K Shares and 4 Insider Buys Not to Miss

Neumaier Kevin S who is President at Ecology & Environment, Inc. (NASDAQ:EEI), bought 2,000 shares at $12.85 per share for a total value of $25,700. The shares recently traded at $12.8999, up $0.05, or 0.39% since the insider buy.

Current Price $13.00

EEI

Wirth Peter who is Chairman of the Board at Rofin-Sinar Technologies Inc. (NASDAQ:RSTI), bought 20,000 shares at $17.11 per share for a total value of $342,200. The shares recently traded at $27.7, up $10.59, or 61.89% since the insider buy.

Current Price $27.82

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

RSTI

Baker Felix who is Director at Genomic Health Inc. (NASDAQ:GHDX), bought 79,984 shares at $28.23 per share for a total value of $2,258,084. The shares recently traded at $28.72, up $0.49, or 1.74% since the insider buy.

Current Price $28.63

GHDX

Isaac Lynn Azar who is Director at Rurban Financial Corp. (NASDAQ:RBNF), bought 500 shares at $7.61 per share for a total value of $3,805. The shares recently traded at $7.6, down $0.01, or 0.13% since the insider buy.

Current Price $7.60

RBNF

Merk Thomas who is COO – Micro at Rofin-Sinar Technologies Inc. (NASDAQ:RSTI), bought 25,000 shares at $17.11 per share for a total value of $427,750. The shares recently traded at $27.7, up $10.59, or 61.89% since the insider buy.

Current Price $27.82

RSTI

Investing Insights: Is Coca-Cola an Outperform?